Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The aim of this study is to investigate and to compare the bioavailability of MP29-02 and fluticasone propionate in nasal tissue after nasal application. This may provide a rational basis for the use of 1 puff per nostril dosage regimen of the drugs. Clinical experience has demonstrated the efficacy of the twice-daily treatment; however, so far, no data are available on the local tissue concentrations of MP29-02 after topical application.
Epistemonikos ID: 943d917b85efbfec321566db74117f645d620e16
First added on: Jun 14, 2024